anastrozole has been researched along with Vaginal Diseases in 6 studies
Vaginal Diseases: Pathological processes of the VAGINA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Endocrine treatments of breast cancer patients antagonize estrogen and may lead to consequences of estrogen deprivation including menopausal symptoms." | 6.71 | Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients. ( Ameye, L; Carbonez, A; Christiaens, MR; Morales, L; Neven, P; Paridaens, R; Timmerman, D; Van Huffel, S; Van Limbergen, E; Vergote, I, 2004) |
| "Endocrine treatments of breast cancer patients antagonize estrogen and may lead to consequences of estrogen deprivation including menopausal symptoms." | 2.71 | Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients. ( Ameye, L; Carbonez, A; Christiaens, MR; Morales, L; Neven, P; Paridaens, R; Timmerman, D; Van Huffel, S; Van Limbergen, E; Vergote, I, 2004) |
| "Breast cancer is one of the most common malignancies in women." | 1.43 | Fractional microablative CO2 laser for vulvovaginal atrophy in women treated with chemotherapy and/or hormonal therapy for breast cancer: a retrospective study. ( Arpino, G; De Placido, G; De Placido, S; De Rosa, P; Locci, M; Nazzaro, G; Pagano, T; Schettini, F; Vallone, R, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Streff, A | 1 |
| Chu-Pilli, M | 1 |
| Stopeck, A | 1 |
| Chalasani, P | 1 |
| Kyvernitakis, I | 1 |
| Ziller, V | 1 |
| Hars, O | 1 |
| Bauer, M | 1 |
| Kalder, M | 1 |
| Hadji, P | 1 |
| Pagano, T | 1 |
| De Rosa, P | 1 |
| Vallone, R | 1 |
| Schettini, F | 1 |
| Arpino, G | 1 |
| De Placido, S | 1 |
| Nazzaro, G | 1 |
| Locci, M | 1 |
| De Placido, G | 1 |
| Vercellini, P | 1 |
| Crosignani, PG | 1 |
| Somigliana, E | 1 |
| Berlanda, N | 1 |
| Barbara, G | 1 |
| Fedele, L | 1 |
| Morales, L | 1 |
| Neven, P | 1 |
| Timmerman, D | 1 |
| Christiaens, MR | 1 |
| Vergote, I | 1 |
| Van Limbergen, E | 1 |
| Carbonez, A | 1 |
| Van Huffel, S | 1 |
| Ameye, L | 1 |
| Paridaens, R | 1 |
| Hefler, LA | 1 |
| Grimm, C | 1 |
| van Trotsenburg, M | 1 |
| Nagele, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Single-arm Phase II Trial to Evaluate Serum Estradiol Levels in Patients With Breast Cancer Treated With Vaginal Estrogen, Estring[NCT01923298] | Phase 2 | 14 participants (Actual) | Interventional | 2013-08-09 | Completed | ||
| Light Emitting Diode for the Treatment of Genitourinary Syndrome of Menopause Associated With Hormonal Therapy for Treating Breast Cancer: Randomized Controlled Clinical Trial[NCT03833726] | 77 participants (Actual) | Interventional | 2019-01-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
To measure changes in serum estradiol level compared to their baseline in patients with breast cancer when treated with vaginal estrogen preparation, Estring (NCT01923298)
Timeframe: Baseline, 16 weeks
| Intervention | pg/mL (Median) |
|---|---|
| Estring Group | 3.9 |
1 review available for anastrozole and Vaginal Diseases
| Article | Year |
|---|---|
Medical treatment for rectovaginal endometriosis: what is the evidence?
Topics: Anastrozole; Aromatase Inhibitors; Cohort Studies; Danazol; Endometriosis; Female; Gonadotropin-Rele | 2009 |
3 trials available for anastrozole and Vaginal Diseases
| Article | Year |
|---|---|
Changes in serum estradiol levels with Estring in postmenopausal women with breast cancer treated with aromatase inhibitors.
Topics: Administration, Intravaginal; Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Estrog | 2021 |
Prevalence of menopausal symptoms and their influence on adherence in women with breast cancer.
Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Anxiety; Aromatase Inhibitors; Breast Neoplasms; | 2014 |
Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients.
Topics: Anastrozole; Aromatase Inhibitors; Belgium; Body Mass Index; Breast Neoplasms; Data Interpretation, | 2004 |
2 other studies available for anastrozole and Vaginal Diseases
| Article | Year |
|---|---|
Fractional microablative CO2 laser for vulvovaginal atrophy in women treated with chemotherapy and/or hormonal therapy for breast cancer: a retrospective study.
Topics: Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Breast Neoplasms; Female; Huma | 2016 |
Role of the vaginally administered aromatase inhibitor anastrozole in women with rectovaginal endometriosis: a pilot study.
Topics: Administration, Intravaginal; Adult; Anastrozole; Aromatase Inhibitors; Chi-Square Distribution; End | 2005 |